Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (361-370 of 551) with videos related to

Pageof 56
Sort By:
Haematologica|March 1, 1991
High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancerL Pierelli, G Menichella, M L Foddai, et al.
British Journal of Haematology|November 1, 1991
Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancerG Menichella, L Pierelli, M L Foddai, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Diagnostic accuracy and economic impact of three work-up strategies identifying risk groups in endometrial cancer, fully incorporating sentinel lymph node algorithmA A Novelli, A Puppo, M Ceccaroni, et al.
Journal of Endocrinological Investigation|July 5, 2015
A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantagesP Villa, A P Lassandro, M C Moruzzi, et al.
International Journal of Cancer|September 4, 1995
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parametersF O Ranelletti, G Scambia, P Benedetti Panici, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgeryG Ferrandina, F O Ranelletti, F Legge, et al.
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2012
Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?F Fanfani, A Fagotti, M G Salerno, et al.
Gynecologic Oncology|September 7, 2010
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgeryG Ferrandina, P A Margariti, D Smaniotto, et al.
Gynecologic Oncology|April 23, 2016
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessmentG Vizzielli, B Costantini, L Tortorella, et al.
Pageof 56

Showing results (361-370 of 551) with videos related to

Sort By:
Pageof 56
Haematologica|March 1, 1991
High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancerL Pierelli, G Menichella, M L Foddai, et al.
British Journal of Haematology|November 1, 1991
Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancerG Menichella, L Pierelli, M L Foddai, et al.
Facts, Views & Vision in Obgyn|October 30, 2020
Diagnostic accuracy and economic impact of three work-up strategies identifying risk groups in endometrial cancer, fully incorporating sentinel lymph node algorithmA A Novelli, A Puppo, M Ceccaroni, et al.
Journal of Endocrinological Investigation|July 5, 2015
A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantagesP Villa, A P Lassandro, M C Moruzzi, et al.
International Journal of Cancer|September 4, 1995
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parametersF O Ranelletti, G Scambia, P Benedetti Panici, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgeryG Ferrandina, F O Ranelletti, F Legge, et al.
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2012
Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?F Fanfani, A Fagotti, M G Salerno, et al.
Gynecologic Oncology|September 7, 2010
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgeryG Ferrandina, P A Margariti, D Smaniotto, et al.
Gynecologic Oncology|April 23, 2016
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessmentG Vizzielli, B Costantini, L Tortorella, et al.
Pageof 56